Algestone acetophenide (DHPA) Powder (24356-94-3) video
Algestone acetophenide (DHPA) Powder (24356-94-3) Specification:
|Chemical Structure:||Product Name: Algestone acetophenide(DHPA)|
|Cas No.: 24356-94-3|
|Molecular Formula: C29H36O4|
|Molecular Weight: 448.59|
|Synonyms: Deladroxone,Alphasone acetophenide,Dihydroxyprogesterone acetophenide|
|Storage: Store at room temperature away from light and moisture.|
|Documents(COA & HPLC etc.): Available|
Algestone acetophenide (DHPA) Powder (24356-94-3) Description:
Algestone acetophenide was discovered in 1958 and was introduced for medical use in the 1960s.It was not introduced in the United States, but it is marketed widely throughout Latin America.It was also previously available alone in Italy and as a combined injectable contraceptive in Portugal and Spain, but has been discontinued in these countries.
Algestone acetophenide(DHPA), also known more commonly as dihydroxyprogesterone acetophenide (DHPA). It is a progestin medication which is used in combination with an estrogen as a form of long-lasting injectable birth control.
Algestone acetophenide powder is a 16alpha,17alpha-dihydroxyprogesterone acetophenide. It has a role as an anti-inflammatory drug and a synthetic oral contraceptive.Kym, Algestone acetophenide powder is a synthetic progesterone that has been used in estrus synchronization and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of acne.
- Philip R.; Carlson, Kathryn E.; Katzenellenbogen, John A. Progestin 16alpha,17alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation. Journal of Medicinal Chemistry. (1993) 36(9): 1111-19.
- Jarquin Gonzalez J D; Elda de Aguirre L; Rodriguez C; Abrego de Aguilar M; Carrillo F; Leon D A; Lima M; Trigueros S; Acosta R. Dihydroxyprogesterone acetophenide 150 mg + estradiol enantate 10 mg as monthly injectable contraceptives Advances in contraception. The Official Journal of the Society for the Advancement of Contraception. (1996) 12(3): 213-25.
- Felton H T; Hoelscher E W; Swartz D P Evaluation of use of an injectable progestin-estrogen for contraception Fertility and sterility (1965), 16(5), 665-75.
PRECAUTION AND DISCLAIMER:
This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.